Michel Lagueux
Inversor de Capital Privado en Gestion Bio Innovation, Inc. .
Perfil
Michel Lagueux is currently the President of Gestion Bio Innovation, Inc. He previously held positions such as Chairman, Interim President & CEO at BioSyntech, Inc., President & Chief Executive Officer at Canacure Corp., Director at Akela Pharma, Inc., Director at Verlyx Pharma, Inc., Vice President at Innovatech Montreal, Inc., Senior Vice President-Life Sciences at Fonds de Solidarité FTQ, and Managing Partner at Multiple Capital, Inc.
Cargos activos de Michel Lagueux
Empresas | Cargo | Inicio |
---|---|---|
Gestion Bio Innovation, Inc.
Gestion Bio Innovation, Inc. Investment ManagersFinance Gestion Bio Innovation Inc (Gestion Bio Innovation) is a venture capital subsidiary of Centre Québécois de Valorisation des Biotechnologies founded in 1900. The firm is headquartered in Quebec, Canada. | Inversor de Capital Privado | - |
Antiguos cargos conocidos de Michel Lagueux.
Empresas | Cargo | Fin |
---|---|---|
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Director/Miembro de la Junta | 19/02/2010 |
BIOSYNTECH, INC. | Presidente | 17/07/2009 |
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Corporate Officer/Principal | 01/05/2008 |
Innovatech Montreal, Inc.
Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Head-Equity Investments | 30/06/2005 |
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BIOSYNTECH, INC. | Health Technology |
Empresas privadas | 7 |
---|---|
Innovatech Montreal, Inc.
Innovatech Montreal, Inc. Investment ManagersFinance Innovatech Montréal, Inc. (IMI) is a Montréal-based venture capital company whose shares the Government of Québec holds. | Finance |
Fonds de Solidarité FTQ
Fonds de Solidarité FTQ Investment ManagersFinance Fonds de Solidarité FTQ (Fonds Régional de Solidarité FTQ) is a private equity firm founded in June 1983. The firm is headquartered in Montréal, Quebec. | Finance |
Multiple Capital, Inc.
Multiple Capital, Inc. Investment ManagersFinance Founded in 2005, formerly Société Innovatech du Grand Montréal, Multiple Capital is a Montréal-based venture capital subsidiary of Collier Capital Ltd. | Finance |
Akela Pharma, Inc.
Akela Pharma, Inc. Pharmaceuticals: MajorHealth Technology Akela Pharma, Inc. operates as a drug development company, which develops and manufactures pharmaceutical formulations and drugs. The company operates as a specialty contract pharmaceutical formulation developer and clinical and commercial drug manufacturer for proprietary drug products through its wholly-owned subsidiary, PharmaForm LLC, a pharmaceutical intellectual property development company. It provides specialty contract services in the area of pharmaceutical dosage form development, preclinical, scale-up, clinical and commercial supply manufacturing, focusing on controlled release and bioavailability enhancement technologies, such as hot melt extrusion, spray drying and liquid filled capsules. Akela Pharma was founded on November 15, 1988 and is headquartered in Austin, TX. | Health Technology |
Gestion Bio Innovation, Inc.
Gestion Bio Innovation, Inc. Investment ManagersFinance Gestion Bio Innovation Inc (Gestion Bio Innovation) is a venture capital subsidiary of Centre Québécois de Valorisation des Biotechnologies founded in 1900. The firm is headquartered in Quebec, Canada. | Finance |
Canacure Corp. | |
Verlyx Pharma, Inc.
Verlyx Pharma, Inc. Pharmaceuticals: MajorHealth Technology Verlyx Pharma, Inc. develops cancer treatments. It is a pharmaceutical company involved in the development of liver-targeting therapeutic agents for the treatment of liver diseases. The firm’s product VLX103, is a proprietary form of pentamidine that combines hepatoselective and hepatoprotective properties. The company was founded in 1999 by Terry Chow and David Griller and is headquartered in Montréal, Canada. | Health Technology |
- Bolsa de valores
- Insiders
- Michel Lagueux